These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 30308249

  • 1. Better With Time: An Economic Assessment of Long-Term Mechanical Circulatory Support in a Population Surviving at Least 1 Year with a Left Ventricular Assist Device.
    Chung JJ, Stetson R, Gordon J, Chen CW, Gaffey AC, Rame JE, Acker M, Atluri P.
    Semin Thorac Cardiovasc Surg; ; 32(4):738-746. PubMed ID: 30308249
    [Abstract] [Full Text] [Related]

  • 2. Vascular complications associated with percutaneous left ventricular assist device placement: A 10-year US perspective.
    Patel N, Sharma A, Dalia T, Rali A, Earnest M, Tadros P, Wiley M, Hockstad E, Mehta A, Thors A, Hance K, Gupta K.
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):309-316. PubMed ID: 31638737
    [Abstract] [Full Text] [Related]

  • 3. Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large Single-Center Study.
    Hernandez RE, Singh SK, Hoang DT, Ali SW, Elayda MA, Mallidi HR, Frazier OH, Meyers DE.
    Tex Heart Inst J; 2015 Oct; 42(5):419-29. PubMed ID: 26504434
    [Abstract] [Full Text] [Related]

  • 4. Clinical Impact of Diabetes Mellitus on Short-Term Outcomes andIn-Hospital Mortality of Cardiac Mechanical Support with Left Ventricular Assist Device (LVAD): A Retrospective Study from a National Database.
    Yassin AS, Subahi A, Adegbala O, Abubakar H, Akintoye E, Ahmed A, Ismail A, Elhag A, Kambal A, Alade A, Shokr M, Weinberger J, Levine D, Afonso L.
    Cardiovasc Revasc Med; 2019 Oct; 20(10):883-886. PubMed ID: 30578171
    [Abstract] [Full Text] [Related]

  • 5. Cost-Effectiveness of Left Ventricular Assist Devices in Ambulatory Patients With Advanced Heart Failure.
    Baras Shreibati J, Goldhaber-Fiebert JD, Banerjee D, Owens DK, Hlatky MA.
    JACC Heart Fail; 2017 Feb; 5(2):110-119. PubMed ID: 28017351
    [Abstract] [Full Text] [Related]

  • 6. Left ventricular assist devices as permanent heart failure therapy: the price of progress.
    Oz MC, Gelijns AC, Miller L, Wang C, Nickens P, Arons R, Aaronson K, Richenbacher W, van Meter C, Nelson K, Weinberg A, Watson J, Rose EA, Moskowitz AJ.
    Ann Surg; 2003 Oct; 238(4):577-83; discussion 583-5. PubMed ID: 14530729
    [Abstract] [Full Text] [Related]

  • 7. Unplanned hospital readmissions after HeartMate II implantation: frequency, risk factors, and impact on resource use and survival.
    Smedira NG, Hoercher KJ, Lima B, Mountis MM, Starling RC, Thuita L, Schmuhl DM, Blackstone EH.
    JACC Heart Fail; 2013 Feb; 1(1):31-9. PubMed ID: 24621797
    [Abstract] [Full Text] [Related]

  • 8. The cost of long-term LVAD implantation.
    Moskowitz AJ, Rose EA, Gelijns AC.
    Ann Thorac Surg; 2001 Mar; 71(3 Suppl):S195-8; discussion S203-4. PubMed ID: 11265862
    [Abstract] [Full Text] [Related]

  • 9. Septuagenarian population has similar survival and outcomes to younger patients after left ventricular assist device implantation.
    Galand V, Flécher E, Chabanne C, Lelong B, Goéminne C, Vincentelli A, Delmas C, Dambrin C, Nubret K, Pernot M, Kindo M, Hoang Minh T, Gaudard P, Frapier JM, Michel M, Sénage T, Boignard A, Chavanon O, Verdonk C, Para M, Pelcé E, Gariboldi V, Pozzi M, Obadia JF, Litlzer PY, Anselme F, Babatasi G, Plane AF, Garnier F, Bielefeld M, Hamon D, Radu C, Bourguignon T, Genet T, Eschalier R, D'Ostrevy N, Bories MC, Marijon E, Vanhuyse F, Blangy H, Leclercq C, Martins RP.
    Arch Cardiovasc Dis; 2020 Nov; 113(11):701-709. PubMed ID: 32952086
    [Abstract] [Full Text] [Related]

  • 10. Cardiac replacement therapies: outcomes and costs for heart transplantation versus circulatory assist.
    Mishra V, Fiane AE, Winsnes BA, Geiran O, Sørensen G, Hagen TP, Gude E.
    Scand Cardiovasc J; 2017 Feb; 51(1):1-7. PubMed ID: 27248460
    [Abstract] [Full Text] [Related]

  • 11. Independent risk factors for ICU mortality after left ventricular assist device implantation.
    Piffard M, Nubret-Le Coniat K, Simon O, Leuillet S, Rémy A, Barandon L, Ouattara A.
    Artif Organs; 2020 Feb; 44(2):153-161. PubMed ID: 31318978
    [Abstract] [Full Text] [Related]

  • 12. Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival.
    Mulloy DP, Bhamidipati CM, Stone ML, Ailawadi G, Kron IL, Kern JA.
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):566-73; discussion 573-4. PubMed ID: 23246055
    [Abstract] [Full Text] [Related]

  • 13. Temporary right ventricular support following left ventricle assist device implantation: a comparison of two techniques.
    Noly PE, Kirsch M, Quessard A, Leger P, Pavie A, Amour J, Leprince P.
    Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):49-55. PubMed ID: 24659551
    [Abstract] [Full Text] [Related]

  • 14. Hospital Readmissions After Continuous-Flow Left Ventricular Assist Device Implantation: Incidence, Causes, and Cost Analysis.
    Akhter SA, Badami A, Murray M, Kohmoto T, Lozonschi L, Osaki S, Lushaj EB.
    Ann Thorac Surg; 2015 Sep; 100(3):884-9. PubMed ID: 26095106
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy.
    Rogers JG, Bostic RR, Tong KB, Adamson R, Russo M, Slaughter MS.
    Circ Heart Fail; 2012 Jan; 5(1):10-6. PubMed ID: 22052901
    [Abstract] [Full Text] [Related]

  • 16. Center Variation in Medicare Spending for Durable Left Ventricular Assist Device Implant Hospitalizations.
    Thompson MP, Pagani FD, Liang Q, Franko LR, Zhang M, McCullough JS, Strobel RJ, Aaronson KD, Kormos RL, Likosky DS, Michigan Congestive Heart Failure Investigators.
    JAMA Cardiol; 2019 Feb 01; 4(2):153-160. PubMed ID: 30698605
    [Abstract] [Full Text] [Related]

  • 17. Thirty-Day Readmissions After Left Ventricular Assist Device Implantation in the United States: Insights From the Nationwide Readmissions Database.
    Agrawal S, Garg L, Shah M, Agarwal M, Patel B, Singh A, Garg A, Jorde UP, Kapur NK.
    Circ Heart Fail; 2018 Mar 01; 11(3):e004628. PubMed ID: 29519902
    [Abstract] [Full Text] [Related]

  • 18. Outcome of patients receiving a continuous flow left ventricular assist device - a retrospective single center study.
    Kiss J, Stark C, Nykänen A, Lemström K.
    Scand Cardiovasc J; 2020 Aug 01; 54(4):212-219. PubMed ID: 32292078
    [Abstract] [Full Text] [Related]

  • 19. Single center outcomes after temporary mechanical circulatory assist device prior to Heartmate 3 implantation - a retrospective cohort study.
    Iversen IJ, Gustafsson F, Rossing K, Møller-Sørensen PH, Olsen PS, Møller CH.
    Scand Cardiovasc J; 2024 Dec 01; 58(1):2353066. PubMed ID: 38962929
    [Abstract] [Full Text] [Related]

  • 20. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ, Scott DA, Loveman E, Colquitt J, Hutchinson J, Royle P, Bryant J.
    Health Technol Assess; 2005 Nov 01; 9(45):1-132, iii-iv. PubMed ID: 16303098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.